Whilst it is not currently mandatory for a HCP to consent for the use of data for the reporting of Transfers of Value (TOV), it is clear from the ‘significant increase’ in numbers from 2015 that HCPs are more confident in showing complete transparency of their interactions with the pharmaceutical industry.

With this increase in numbers, certainly for the UK and likely repeated across Europe, it underlines the requirement for venues to proactively provide unbundled rates and speed up the process of meeting enquiry and booking.

To read the full ABPI report, Click Here